Lung Cancer

Outlook for lung cancer patients remains grim

05/02/2010 | The prognosis for lung cancer patients remains poor, with most still diagnosed with advanced disease, a study from Western Australia shows.


Age should not affect chemo choice in stage IV lung cancer

04/12/2009 | In an update to its 2003 guidelines for stage IV non-small-cell lung cancer chemotherapy, the American Society of Clinical Oncology says that age alone should not affect the choice of treatment protocol.


Co-ordination of care important

20/11/2009 | A study looking at expectations and preferences for follow-up care in lung cancer patients has found that the majority of patients place the most importance on seeing the same doctor or health care professional at each visit.


More chemotherapy may not be better in NSCLC

04/11/2009 | A meta-analysis by Australian authors that demonstrated a small OS gain in patients with NSCLC exposed to a longer duration of chemotherapy has been criticised by Brazilian oncologists.


HRT increases risk of death from lung cancer

22/09/2009 | Women taking hormone therapy who develop lung cancer are more likely to die from the disease than non-users, research shows. 1 comment


Large-scale screening could help target therapy

04/09/2009 | Screening lung cancer patients for the EGFR gene mutation could help identify those who will benefit most from treatment with the tyrosine kinase inhibitor erlotinib, Spanish research shows.


EML4-ALK tumours resistant to EGFR TKIs

14/08/2009 | The EML4-ALK fusion oncogene defines a molecular subset of non-small-cell lung cancers that do not benefit from EGFR tyrosine kinase inhibitors, research shows.


Duration of chemotherapy: Is more better?

16/07/2009 | Extending chemotherapy beyond a standard number of cycles delays disease progression substantially but has only modest effects on overall survival in patients with advanced NSCLC, a meta-analysis by Australian oncologists concludes.


PET-CT staging of lung cancer reduces futile thoracotomies

02/07/2009 | Adding combined PET-CT imaging to conventional staging in patients suspected of having operable non-small-cell lung cancer reduces the number of futile thoracotomies but does not affect mortality, Danish oncologists have concluded.


HRT raises risk of death from NSCLC

04/06/2009 | Hormone therapy with oestrogen plus progestin for more than 5 years increased the risk of death in women diagnosed with non-small cell lung cancer, a secondary analyses from the Women's Health Initiative finds.


More Lung Cancer news

Journals

Members of Oncology Update can access the following journals for free:

Most viewed articles this week

Recent comments

Related sites